A61P 25/22 :
Anxiolytics
A61P 25/24 :
Antidepressants
A61P 25/28 :
for treating neurodegenerat...
A61P 27/02 :
Ophthalmic agents
A61P 27/06 :
Antiglaucoma agents or miotics
A61P 29/00 :
Non-central analgesic, anti...
A61P 3/06 :
Antihyperlipidemics
A61P 3/10 :
for hyperglycaemia, e.g. an...
A61P 31/04 :
Antibacterial agents
A61P 31/12 :
Antivirals
A61P 31/18 :
for HIV
A61P 33/00 :
Antiparasitic agents
A61P 35/00 :
Antineoplastic agents
A61P 35/02 :
specific for leukemia
A61P 37/00 :
Drugs for immunological or ...
A61P 37/02 :
Immunomodulators
A61P 37/06 :
Immunosuppressants, e.g. dr...
A61P 43/00 :
Drugs for specific purposes...
A61P 5/00 :
Drugs for disorders of the ...
A61P 5/14 :
of the thyroid hormones, e....
A61P 5/18 :
of the parathyroid hormones
A61P 7/00 :
Drugs for disorders of the ...
A61P 7/02 :
Antithrombotic agents; Anti...
A61P 7/06 :
Antianaemics
A61P 9/00 :
Drugs for disorders of the ...
A61P 9/10 :
for treating ischaemic or a...
A61P 9/12 :
Antihypertensives
C07C 229/30 :
the carbon skeleton being a...
C07K 1/1075 :
by covalent attachment of a...
C07K 1/113 :
without change of the prima...
C07K 14/001 :
by chemical synthesis
C07K 14/005 :
from viruses
C07K 14/4705 :
stimulating, promoting or a...
C07K 14/4746 :
p53
C07K 14/4747 :
Apoptosis related proteins
C07K 14/605 :
Glucagons
C07K 14/705 :
Receptors; Cell surface ant...
C07K 7/06 :
having 5 to 11 amino acids
C07K 7/08 :
having 12 to 20 amino acids...
C12N 2740/16322 :
New viral proteins or indiv...
C12N 2770/24222 :
New viral proteins or indiv...
C12N 7/00 :
Viruses; Bacteriophages; Co...
C12N 9/22 :
Ribonucleases RNAses, DNAse...
C12Y 301/00 :
Hydrolases acting on ester ...